AR Signaling and the PI3K Pathway in Prostate Cancer
Author:
Publisher
MDPI AG
Subject
Cancer Research,Oncology
Link
http://www.mdpi.com/2072-6694/9/4/34/pdf
Reference107 articles.
1. Prostate Cancer Incidence, Mortality and Prevalence Worldwidehttp://globocan.iarc.fr/Pages/online.aspx
2. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
3. Abiraterone and Increased Survival in Metastatic Prostate Cancer
4. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
5. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N. Engl. J. Med.,2012
Cited by 123 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advancements in dual-target inhibitors of PI3K for tumor therapy: Clinical progress, development strategies, prospects;European Journal of Medicinal Chemistry;2024-02
2. Histone methyltransferase SUV39H2 regulates apoptosis and chemosensitivity in prostate cancer through AKT/FOXO signaling pathway;Medical Oncology;2024-01-03
3. PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression;Oncogene;2023-10-24
4. Nanodrug Delivery Strategies to Signaling Pathways in Alopecia;Molecular Pharmaceutics;2023-10-11
5. Molecular Anatomy of Prostate Cancer and Its Implications in Active Surveillance and Early Intervention Strategies;Anatomia;2023-10-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3